{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:35:57Z","timestamp":1790516157473,"version":"4.1.0"},"reference-count":42,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Hairy cell leukemia (HCL) is characterized by abnormal villous lymphoid cells that express CD103, CD123, CD25 and CD11c. HCL-like disorders, including hairy cell leukemia variant (vHCL) and splenic diffuse red pulp lymphoma (SDRPL), have similar morphologic criteria and a distinct phenotypic and genetic profile. We investigated the immunophenotypic features of a large cohort of 82 patients: 68 classical HCL, 5 vHCL\/SDRPL and 9 HCL-like NOS. The HCL immunophenotype was heterogeneous: positive CD5 expression in 7\/68 (10%), CD10 in 12\/68 (18%), CD38 in 24\/67 (36%), CD23 in 22\/68 (32%) and CD43 in 19\/65 (31%) patients. CD26 was expressed in 35\/36 (97%) of HCL patients, none of vHCL\/SDRPL and one of seven HCL-like NOS (14%). When adding CD26 to the immunologic HCL scoring system (one point for CD103, CD123, CD25, CD11c and CD26), the specificity was improved, increasing from 78.6% to 100%. We used unsupervised analysis of flow cytometry raw data (median fluorescence, percentage of expression) and the mutational profile of BRAF, MAP2K1 and KLF2. The analysis showed good separation between HCL and vHCL\/SDRPL. The HCL score is not sufficient, and the use of unsupervised analysis could be promising to achieve a distinction between HCL and HCL-like disorders. However, these preliminary results have to be confirmed in a further study with a higher number of patients.<\/jats:p>","DOI":"10.3390\/cancers14041050","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T08:14:46Z","timestamp":1645431286000},"page":"1050","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5967-8225","authenticated-orcid":false,"given":"Elsa","family":"Maitre","sequence":"first","affiliation":[{"name":"INSERM1245, MICAH, Normandie University of Caen and Rouen, UNIROUEN, UNICAEN, Avenue de la C\u00f4te de Nacre, 14033 Caen, France"},{"name":"Laboratory of Hematology, University Hospital Caen, Avenue de la C\u00f4te de Nacre, 14033 Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1667-3421","authenticated-orcid":false,"given":"Edouard","family":"Cornet","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, University Hospital Caen, Avenue de la C\u00f4te de Nacre, 14033 Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Sala\u00fcn","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, University Hospital Caen, Avenue de la C\u00f4te de Nacre, 14033 Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Kerneves","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, University Hospital Caen, Avenue de la C\u00f4te de Nacre, 14033 Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Ch\u00e8ze","sequence":"additional","affiliation":[{"name":"Hematology Institute, University Hospital Caen, Avenue de la C\u00f4te de Nacre, 14033 Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohan","family":"Repesse","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, University Hospital Caen, Avenue de la C\u00f4te de Nacre, 14033 Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gandhi","family":"Damaj","sequence":"additional","affiliation":[{"name":"INSERM1245, MICAH, Normandie University of Caen and Rouen, UNIROUEN, UNICAEN, Avenue de la C\u00f4te de Nacre, 14033 Caen, France"},{"name":"Hematology Institute, University Hospital Caen, Avenue de la C\u00f4te de Nacre, 14033 Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Troussard","sequence":"additional","affiliation":[{"name":"INSERM1245, MICAH, Normandie University of Caen and Rouen, UNIROUEN, UNICAEN, Avenue de la C\u00f4te de Nacre, 14033 Caen, France"},{"name":"Hematology Institute, University Hospital Caen, Avenue de la C\u00f4te de Nacre, 14033 Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood.V13.7.609.609","article-title":"Leukemic reticuloendotheliosis","volume":"13","author":"Bouroncle","year":"1958","journal-title":"Blood"},{"key":"ref_2","unstructured":"Swerdlow, S., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., and Thiele, J. (2017). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Troussard, X. (2020). Epidemiology of hairy cell leukemia (HCL) and HCL-like disorders. Med. Res. Arch., 8.","DOI":"10.18103\/mra.v8i10.2259"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2015-11-680074","article-title":"BRAF inhibition in hairy cell leukemia with low-dose vemurafenib","volume":"127","author":"Dietrich","year":"2016","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJMoa1506583","article-title":"Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia","volume":"373","author":"Tiacci","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Weston-Bell, N.J., Forconi, F., Kluin-Nelemans, H.C., and Sahota, S.S. (2014). Variant B cell receptor isotype functions differ in hairy cell leukemia with mutated BRAF and IGHV genes. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086556"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1080\/10428194.2016.1239262","article-title":"Ibrutinib for relapsed refractory hairy cell leukemia variant","volume":"58","author":"Bohn","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bjh.12867","article-title":"The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: A new therapeutic approach","volume":"166","author":"Sivina","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_11","first-page":"57","article-title":"The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes","volume":"14","author":"Matutes","year":"1994","journal-title":"Leuk. Lymphoma"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1111\/ijlh.12824","article-title":"Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL","volume":"40","author":"Favre","year":"2018","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1309\/AJCPEBK31VQQNDDR","article-title":"CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders","volume":"140","author":"Pillai","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_14","first-page":"303","article-title":"The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes","volume":"89","author":"Matutes","year":"2004","journal-title":"Haematologica"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.2828","article-title":"High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias","volume":"46","author":"Waterfall","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2141.2012.09163.x","article-title":"The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma","volume":"158","author":"Hockley","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Yilmaz, E., Chhina, A., Nava, V.E., and Aggarwal, A. (2021). A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma. Curr. Oncol., 28.","DOI":"10.3390\/curroncol28060431"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2007-07-098848","article-title":"Splenic Red Pulp Lymphoma with Numerous Basophilic Villous Lymphocytes: A Distinct Clinicopathologic and Molecular Entity?","volume":"111","author":"Baseggio","year":"2008","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2016-11-751024","article-title":"Splenic Diffuse Red Pulp Small B-Cell Lymphoma Displays Increased Expression of Cyclin D3 and Recurrent CCND3 Mutations","volume":"129","author":"Almaraz","year":"2017","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Jallades, L., Baseggio, L., Sujobert, P., Huet, S., Chabane, K., Callet-Bauchu, E., Verney, A., Hayette, S., Desvignes, J.-P., and Salgado, D. (2017). Exome Sequencing Identifies Recurrent BCOR Gene Alterations and the Absence of KLF2, TNFAIP3 and MYD88 Mutations in Splenic Diffuse Red Pulp Small B-Cell Lymphoma. Haematologica, 1758\u20131766.","DOI":"10.3324\/haematol.2016.160192"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Troussard, X., Maitre, E., and Cornet, E. (2021). Hairy Cell Leukemia 2022: Update on Diagnosis, Risk-stratification, and Treatment. Am. J. Hematol.","DOI":"10.1002\/ajh.26390"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.18632\/oncotarget.25601","article-title":"New Generation Sequencing of Targeted Genes in the Classical and the Variant Form of Hairy Cell Leukemia Highlights Mutations in Epigenetic Regulation Genes","volume":"9","author":"Maitre","year":"2018","journal-title":"Oncotarget"},{"key":"ref_23","first-page":"1","article-title":"FactoMineR: An R Package for Multivariate Analysis","volume":"25","author":"Josse","year":"2008","journal-title":"J. Stat. Softw."},{"key":"ref_24","unstructured":"Kassambara, A., Kosinski, M., and Biecek, P. (2021, October 25). P. Survminer: Drawing Survival Curves Using \u201cGgplot2\u201d. R cran. Available online: https:\/\/cran.r-project.org\/web\/packages\/survminer\/survminer.pdf."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20031175","article-title":"Gene Expression Profiling of Hairy Cell Leukemia Reveals a Phenotype Related to Memory B Cells with Altered Expression of Chemokine and Adhesion Receptors","volume":"199","author":"Basso","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_26","first-page":"266","article-title":"Absence of Surface CD27 Distinguishes Hairy Cell Leukemia from Other Leukemic B-Cell Malignancies","volume":"90","author":"Forconi","year":"2005","journal-title":"Haematologica"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1309\/PMQXVY619Q8Y43AR","article-title":"Immunophenotypic Variations in Hairy Cell Leukemia","volume":"125","author":"Chen","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cyto.b.21365","article-title":"CD5 Positive Hairy Cell Leukemia: A Rare Case Report with Brief Review of Literature","volume":"90","author":"Jain","year":"2016","journal-title":"Cytom. Part B Clin. Cytom."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1309\/QVJD31TEG9UJ18BQ","article-title":"Analysis of CD10+ Hairy Cell Leukemia","volume":"120","author":"Jasionowski","year":"2003","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1182\/blood.V83.12.3672.3672","article-title":"Flow Cytometry of Blood and Bone Marrow Cells from Patients with Hairy Cell Leukemia: Phenotype of Hairy Cells and Lymphocyte Subsets after Treatment with 2-Chlorodeoxyadenosine","volume":"83","author":"Juliusson","year":"1994","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cyto.b.21785","article-title":"Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia","volume":"96","author":"Salem","year":"2019","journal-title":"Cytometry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1158\/0008-5472.CAN-15-0893","article-title":"CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for Therapy","volume":"75","author":"Poret","year":"2015","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11864-014-0285-5","article-title":"Update on the Biology and Treatment Options for Hairy Cell Leukemia","volume":"15","author":"Jain","year":"2014","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41408-020-00384-1","article-title":"Hairy Cell Leukemia Expresses Programmed Death-1","volume":"10","author":"Kumar","year":"2020","journal-title":"Blood Cancer J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"19056","DOI":"10.1038\/s41598-021-98536-1","article-title":"Dissection of the Bone Marrow Microenvironment in Hairy Cell Leukaemia Identifies Prognostic Tumour and Immune Related Biomarkers","volume":"11","author":"Koldej","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41379-018-0093-8","article-title":"Clinicopathologic and Molecular Features in Hairy Cell Leukemia-Variant: Single Institutional Experience","volume":"31","author":"Angelova","year":"2018","journal-title":"Mod. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1182\/blood-2009-01-201731","article-title":"VH4-34+ Hairy Cell Leukemia, a New Variant with Poor Prognosis despite Standard Therapy","volume":"114","author":"Arons","year":"2009","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hon.888","article-title":"CD26 Expression in Mature B-Cell Neoplasia: Its Possible Role as a New Prognostic Marker in B-CLL","volume":"27","author":"Cro","year":"2009","journal-title":"Hematol. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1182\/bloodadvances.2021005725","article-title":"Expert-Independent Classification of Mature B-Cell Neoplasms Using Standardized Flow Cytometry: A Multicentric Study","volume":"6","author":"Engelmann","year":"2022","journal-title":"Blood Adv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2011-09-379339","article-title":"Both Variant and IGHV4-34\u2013Expressing Hairy Cell Leukemia Lack the BRAF V600E Mutation","volume":"119","author":"Xi","year":"2012","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1182\/blood-2009-03-212449","article-title":"Hairy Cell Leukemias with Unmutated IGHV Genes Define the Minor Subset Refractory to Single-Agent Cladribine and with More Aggressive Behavior","volume":"114","author":"Forconi","year":"2009","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.beha.2015.09.002","article-title":"Hairy Cell Leukaemia-Variant: Disease Features and Treatment","volume":"28","author":"Matutes","year":"2015","journal-title":"Best Pract. Res. Clin. Haematol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/4\/1050\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:22:38Z","timestamp":1760134958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/4\/1050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["cancers14041050"],"URL":"https:\/\/doi.org\/10.3390\/cancers14041050","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]}}}